Inaugural ALGS Open Launches in New Orleans with $1M Prize Pool
The inaugural ALGS Open is set to begin at the Ernest N. Morial Convention Center from May 1-4, 2025, marking what is ...
ALGS returns to the United States for biggest Apex LAN in history
The ALGS Open will take place in New Orleans, LA from May 1-4, with a massive 160 Apex teams participating in the first ...
Bleeding Cool5h
Apex Legends Announces Inaugural ALGS Open in New Orleans
Apex Legends will hold one of its biggest events to date in New Orleans this May, as the ALGS Open will feature 160 Pro ...
Aligos Therapeutics announces inducement grants under Nasdaq listing rule
Aligos Therapeutics (ALGS) announced that the Compensation Committee of the Company’s Board of Directors granted a non-qualified stock option ...
Aligos Therapeutics price target lowered to $70 from $75 at H.C. Wainwright
H.C. Wainwright lowered the firm’s price target on Aligos Therapeutics (ALGS) to $70 from $75 and keeps a Buy rating on the shares. The firm is ...
Aligos Therapeutics (ALGS) to Release Quarterly Earnings on Monday
Aligos Therapeutics (NASDAQ:ALGS – Get Free Report) is expected to be releasing its earnings data before the market opens on ...
HC Wainwright Has Lowered Expectations for Aligos Therapeutics (NASDAQ:ALGS) Stock Price
Aligos Therapeutics (NASDAQ:ALGS – Get Free Report) had its price objective cut by equities research analysts at HC Wainwright from $75.00 to $70.00 in a research note issued on Tuesday,Benzinga ...
Yahoo Finance5d
Aligos Therapeutics, Inc. (ALGS)
SOUTH SAN FRANCISCO, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biotechnology company focused on improving patient outcomes through best ...
IiTzTimmy, Verhulst, and more Apex stars land with new teams as ALGS offseason heats up
Rostermania rages on in North America with many of Apex's biggest names finding themselves new homes. With year five of the ...
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral ...